Walgreens Boots Alliance, Inc. (WBA) to Issue Quarterly Dividend of $0.25 on December 12th

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) announced a quarterly dividend on Thursday, October 24th, RTT News reports. Stockholders of record on Monday, November 18th will be given a dividend of 0.25 per share by the pharmacy operator on Thursday, December 12th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.80%.

Walgreens Boots Alliance has increased its dividend by an average of 1.3% annually over the last three years. Walgreens Boots Alliance has a dividend payout ratio of 59.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Walgreens Boots Alliance to earn $1.58 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 63.3%.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $9.26 on Friday. The company has a market cap of $7.99 billion, a PE ratio of -1.37, a price-to-earnings-growth ratio of 1.24 and a beta of 0.70. Walgreens Boots Alliance has a twelve month low of $8.22 and a twelve month high of $27.05. The company’s 50-day moving average price is $9.34 and its 200-day moving average price is $12.88. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm’s revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.67 EPS. On average, equities research analysts forecast that Walgreens Boots Alliance will post 1.57 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently commented on WBA. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Royal Bank of Canada cut their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 2nd. UBS Group boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.